Board of Shukra Pharmaceuticals approves change in CEO and appointment of director

The Board of Shukra Pharmaceuticals at its meeting held on 11 May 2020 has approved the appointment of Mehul Patel as Chief Financial Officer [KMPJ of the Company. The Board has also appointed Ashvin Trivedi [DIN: 032L2457) as an additional Non-executive director of the Company. Further, the Board has accepted and taken note of Resignation of Karnik Shah as Chief Executive Officer [CEO) of the Company,

Powered by Capital Market - Live News